◆ AI Clinical Summary
Plain-language summary for patients
Trial Parameters
Condition Sepsis Due to Streptococcus, Group A
Sponsor Association Clinique Thérapeutique Infantile du val de Marne
Study Type OBSERVATIONAL
Phase N/A
Enrollment 100
Sex ALL
Min Age 1 Day
Max Age 17 Years
Start Date 2022-09-01
Completion 2026-09-01
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
Brief Summary
This study is observational, retrospective and prospective study in pediatric patients hospitalized with invasive streptococcal A infection
Eligibility Criteria
Inclusion Criteria: * Age\<18 years * Documented invasive Group A Streptococcus infection (identification of GAS in a normally sterile site or from another site in case of toxin shock or necrotizing dermo-hypodermatitis) Exclusion Criteria: * Opposition of the patient or his/her legal representative
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology